| Three component chimeric antisense oligonucleotides A Arrow, RMK Dale, TM Woolf US Patent 5,849,902, 1998 | 371 | 1998 |
| Specificity of antisense oligonucleotides in vivo. TM Woolf, DA Melton, CG Jennings Proceedings of the National Academy of Sciences 89 (16), 7305-7309, 1992 | 352 | 1992 |
| Input Device Having Multifunctional Keys TM Woolf, AS Marks US Patent App. 11/996,722, 2008 | 327 | 2008 |
| Oligonucleotide compositions with enhanced efficiency T Woolf, M Taylor US Patent App. 10/357,826, 2004 | 242 | 2004 |
| The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos TM Woolf, CGB Jennings, M Rebagliati, DA Melton Nucleic acids research 18 (7), 1763-1769, 1990 | 209 | 1990 |
| Nucleic acid molecules with novel chemical compositions capable of modulating gene expression J Thompson, L Beigelman, J McSwiggen, A Karpeisky, L Bellon, ... US Patent 6,673,611, 2004 | 206 | 2004 |
| Sense mrna therapy K Wiederholt, T Woolf, M Taylor US Patent App. 09/156,323, 2003 | 206 | 2003 |
| Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein MZ Wang, P Jin, DA Bumcrot, V Marigo, AP Mcmahon, EA Wang, T Woolf, ... Nature medicine 1 (11), 1184-1188, 1995 | 195 | 1995 |
| SENSE mRNA THERAPY T Woolf, K Wiederholt, M Taylor US Patent App. 12/185,012, 2009 | 191 | 2009 |
| Double-stranded oligonucleotides T Woolf, K Wiederholt US Patent App. 10/357,529, 2004 | 182 | 2004 |
| Three component chimeric antisense oligonucleotides A Arrow, RMK Dale, TM Woolf US Patent 5,989,912, 1999 | 163 | 1999 |
| Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult in vitro N Miao, M Wang, JA Ott, JS D’Alessandro, TM Woolf, DA Bumcrot, ... Journal of Neuroscience 17 (15), 5891-5899, 1997 | 157 | 1997 |
| Expression of activin mRNA during early development in Xenopus laevis CE Dohrmann, A Hemmati-Brivanlou, GH Thomsen, A Fields, TM Woolf, ... Developmental biology 157 (2), 474-483, 1993 | 136 | 1993 |
| Double-stranded oligonucleotides T Woolf US Patent App. 11/049,636, 2006 | 123 | 2006 |
| Modified RNAi polynucleotides and uses thereof PA Pavco, J Kamens, TM Woolf, W Salomon, A Khvorova US Patent 10,131,904, 2018 | 118 | 2018 |
| Toward the therapeutic editing of mutated RNA sequences. TM Woolf, JM Chase, DT Stinchcomb Proceedings of the National Academy of Sciences 92 (18), 8298-8302, 1995 | 118 | 1995 |
| Optimizing the cell efficacy of synthetic ribozymes: site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb TC Jarvis, FE Wincott, LJ Alby, JA McSwiggen, L Beigelman, J Gustofson, ... Journal of Biological Chemistry 271 (46), 29107-29112, 1996 | 113 | 1996 |
| Reduced size self-delivering RNAi compounds A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia US Patent 10,041,073, 2018 | 96 | 2018 |
| Reduced size self-delivering RNAi compounds A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia US Patent 8,796,443, 2014 | 94 | 2014 |
| Reduced size self-delivering RNAi compounds A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia US Patent 9,175,289, 2015 | 74 | 2015 |
